Funding for this research was provided by:
Università degli Studi di Palermo
Received: 4 October 2020
Accepted: 23 November 2020
First Online: 2 December 2020
Compliance with ethical standards
: MN acted as the consultant for Bayer, BIOFVIIIx, Novonordisk, and Amgen, and received speaker fees from Kedrion, Octapharma, Baxalta, CSLBehring, Novonordisk, Bayer, and Sobi. All other authors have no relevant conflicts of interest to declare.